Literature DB >> 20720589

Pituitary gland: New consensus in acromegaly: criteria for cure and control.

Nienke Biermasz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20720589     DOI： 10.1038/nrendo.2010.129

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  Criteria for cure of acromegaly: a consensus statement.

Authors:  A Giustina; A Barkan; F F Casanueva; F Cavagnini; L Frohman; K Ho; J Veldhuis; J Wass; K Von Werder; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  2000-02       Impact factor: 5.958

2.  Grading quality of evidence and strength of recommendations.

Authors:  David Atkins; Dana Best; Peter A Briss; Martin Eccles; Yngve Falck-Ytter; Signe Flottorp; Gordon H Guyatt; Robin T Harbour; Margaret C Haugh; David Henry; Suzanne Hill; Roman Jaeschke; Gillian Leng; Alessandro Liberati; Nicola Magrini; James Mason; Philippa Middleton; Jacek Mrukowicz; Dianne O'Connell; Andrew D Oxman; Bob Phillips; Holger J Schünemann; Tessa Tan-Torres Edejer; Helena Varonen; Gunn E Vist; John W Williams; Stephanie Zaza
Journal:  BMJ       Date:  2004-06-19

Review 3.  Medical progress: Acromegaly.

Authors:  Shlomo Melmed
Journal:  N Engl J Med       Date:  2006-12-14       Impact factor: 91.245

4.  Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.

Authors:  P J Trainer; W M Drake; L Katznelson; P U Freda; V Herman-Bonert; A J van der Lely; E V Dimaraki; P M Stewart; K E Friend; M L Vance; G M Besser; J A Scarlett; M O Thorner; C Parkinson; A Klibanski; J S Powell; A L Barkan; M C Sheppard; M Malsonado; D R Rose; D R Clemmons; G Johannsson; B A Bengtsson; S Stavrou; D L Kleinberg; D M Cook; L S Phillips; M Bidlingmaier; C J Strasburger; S Hackett; K Zib; W F Bennett; R J Davis
Journal:  N Engl J Med       Date:  2000-04-20       Impact factor: 91.245

5.  Long-acting somatostatin analog therapy of acromegaly: a meta-analysis.

Authors:  Pamela U Freda; Laurence Katznelson; Aart Jan van der Lely; Carlos M Reyes; Shouhao Zhao; Daniel Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  2005-05-10       Impact factor: 5.958

6.  Combined therapy with somatostatin analogues and weekly pegvisomant in active acromegaly.

Authors:  J Feenstra; W W de Herder; S M T H ten Have; A W van den Beld; R A Feelders; J A M J L Janssen; A J van der Lely
Journal:  Lancet       Date:  2005 May 7-13       Impact factor: 79.321

7.  A consensus on criteria for cure of acromegaly.

Authors:  A Giustina; P Chanson; M D Bronstein; A Klibanski; S Lamberts; F F Casanueva; P Trainer; E Ghigo; K Ho; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  2010-04-21       Impact factor: 5.958

8.  AcroBel--the Belgian registry on acromegaly: a survey of the 'real-life' outcome in 418 acromegalic subjects.

Authors:  Marie Bex; Roger Abs; Guy T'Sjoen; Jean Mockel; Brigitte Velkeniers; Katja Muermans; Dominique Maiter
Journal:  Eur J Endocrinol       Date:  2007-10       Impact factor: 6.664

9.  Epidemiology, clinical characteristics, outcome, morbidity and mortality in acromegaly based on the Spanish Acromegaly Registry (Registro Espanol de Acromegalia, REA).

Authors:  Antonio Mestron; Susan M Webb; Ricardo Astorga; Pedro Benito; Miguel Catala; Sonia Gaztambide; Jose-Manuel Gomez; Irene Halperin; Tomas Lucas-Morante; Basilio Moreno; Gabriel Obiols; Pedro de Pablos; Concha Paramo; Antonio Pico; Elena Torres; Cesar Varela; Jose-Antonio Vazquez; Juana Zamora; Merce Albareda; Montserrat Gilabert
Journal:  Eur J Endocrinol       Date:  2004-10       Impact factor: 6.664

10.  Mortality in acromegaly: a metaanalysis.

Authors:  O M Dekkers; N R Biermasz; A M Pereira; J A Romijn; J P Vandenbroucke
Journal:  J Clin Endocrinol Metab       Date:  2007-10-30       Impact factor: 5.958
  10 in total
  1 in total

1.  Multiple facets in the control of acromegaly.

Authors:  Lucio Vilar; Alex Valenzuela; Antônio Ribeiro-Oliveira; Claudia M Gómez Giraldo; Doly Pantoja; Marcello D Bronstein
Journal:  Pituitary       Date:  2014-01       Impact factor: 4.107
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.